(Q74136801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Interferon-beta treatment alters peripheral blood monocytes chemokine production in MS patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

3

Howard L Weiner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

Jaime Imitola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Manuel Comabella

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

205-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

Macrophage inflammatory protein-1 alpha activates basophils and mast cells

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Activation of dual T cell signaling pathways by the chemokine RANTES

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

The role of CD40 ligand in costimulation and T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Differential induction of chemokines in human microglia by type I and II interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Regulation of cytokine and chemokine transcription in a human TH2 type T-cell clone during the induction phase of anergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Management of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900064-4

7 January 2021

10.1016/S0165-5728(02)00064-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12020972%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference